Image Credit: STAT News
STAT+: As Trump pauses enforcement of an anti-bribery law, will pharma engage in bad behavior?
The Trump administration's decision to pause enforcement of an anti-bribery law raised the specter that drugmakers could engage in bad behavior as a result.